Unity and diversity in the human adenoviruses: exploiting alternative entry pathways for gene therapy
- PMID: 20937040
- DOI: 10.1042/BJ20100766
Unity and diversity in the human adenoviruses: exploiting alternative entry pathways for gene therapy
Abstract
Human Ads (adenoviruses) have been extensively utilized for the development of vectors for gene transfer, as they infect many cell types and do not integrate their genome into host-cell chromosomes. In addition, they have been widely studied as cytolytic viruses, termed oncolytic adenoviruses in cancer therapy. Ads are non-enveloped viruses with a linear double-stranded DNA genome of 30-38 kb which encodes 30-40 genes. At least 52 human Ad serotypes have been identified and classified into seven species, A-G. The Ad capsid has icosahedral symmetry and is composed of 252 capsomers, of which 240 are located on the facets of the capsid and consist of a trimeric hexon protein and the remaining 12 capsomers, the pentons, are at the vertices and comprise the penton base and projecting fibre protein. The entry of Ads into human cells is a two-step process. In the first step, the fibre protein mediates a primary interaction with the cell, effectively tethering the virus particle to the cell surface via a cellular attachment protein. The penton base then interacts with cell-surface integrins, leading to virus internalization. This interaction of the fibre protein with a number of cell-surface molecules appears to be important in determining the tropism of adenoviruses. Ads from all species, except species B and certain serotypes of species D, utilize CAR (coxsackie and adenovirus receptor) as their primary cellular-attachment protein, whereas most species B Ads use CD46, a complement regulatory protein. Such species-specific differences, as well as adaptations or modifications of Ads required for applications in gene therapy, form the major focus of the present review.
Similar articles
-
Human adenovirus binding to host cell receptors: a structural view.Med Microbiol Immunol. 2020 Jun;209(3):325-333. doi: 10.1007/s00430-019-00645-2. Epub 2019 Nov 29. Med Microbiol Immunol. 2020. PMID: 31784892 Free PMC article. Review.
-
Tropism and transduction of oncolytic adenovirus 5 vectors in cancer therapy: Focus on fiber chimerism and mosaicism, hexon and pIX.Virus Res. 2018 Sep 15;257:40-51. doi: 10.1016/j.virusres.2018.08.012. Epub 2018 Aug 17. Virus Res. 2018. PMID: 30125593 Review.
-
Human species D adenovirus hexon capsid protein mediates cell entry through a direct interaction with CD46.Proc Natl Acad Sci U S A. 2021 Jan 19;118(3):e2020732118. doi: 10.1073/pnas.2020732118. Proc Natl Acad Sci U S A. 2021. PMID: 33384338 Free PMC article.
-
A quasi-atomic model of human adenovirus type 5 capsid.EMBO J. 2005 May 4;24(9):1645-54. doi: 10.1038/sj.emboj.7600653. Epub 2005 Apr 21. EMBO J. 2005. PMID: 15861131 Free PMC article.
-
State-of-the-art human adenovirus vectorology for therapeutic approaches.FEBS Lett. 2019 Dec;593(24):3609-3622. doi: 10.1002/1873-3468.13691. Epub 2019 Dec 9. FEBS Lett. 2019. PMID: 31758807 Review.
Cited by
-
Influence of cell physiological state on gene delivery to T lymphocytes by chimeric adenovirus Ad5F35.Sci Rep. 2016 Mar 14;6:22688. doi: 10.1038/srep22688. Sci Rep. 2016. PMID: 26972139 Free PMC article.
-
Viral Gene Therapy for Glioblastoma Multiforme: A Promising Hope for the Current Dilemma.Front Oncol. 2021 May 13;11:678226. doi: 10.3389/fonc.2021.678226. eCollection 2021. Front Oncol. 2021. PMID: 34055646 Free PMC article. Review.
-
Downregulation of Mdm2 and Mdm4 enhances viral gene expression during adenovirus infection.Cell Cycle. 2012 Feb 1;11(3):582-93. doi: 10.4161/cc.11.3.19052. Epub 2012 Feb 1. Cell Cycle. 2012. PMID: 22262167 Free PMC article.
-
Overcoming tumor resistance by heterologous adeno-poxvirus combination therapy.Mol Ther Oncolytics. 2015 Jan 7;1:14006. doi: 10.1038/mto.2014.6. eCollection 2015. Mol Ther Oncolytics. 2015. PMID: 27119097 Free PMC article.
-
The dual role of complement in cancer and its implication in anti-tumor therapy.Ann Transl Med. 2016 Jul;4(14):265. doi: 10.21037/atm.2016.06.26. Ann Transl Med. 2016. PMID: 27563652 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical